Biomarkers of platelet activation and cardiovascular risk in the DAPT trial-Reference-Cited by-同舟云学术

Biomarkers of platelet activation and cardiovascular risk in the DAPT trial

Published:2020-07-18 Issue:3 Volume:51 Page:675-681
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Berg David D.^ORCID,Yeh Robert W.,Mauri Laura,Morrow David A.,Kereiakes Dean J.,Cutlip Donald E.,Gao Qi,Jarolim Petr,Michelson Alan D.,Frelinger Andrew L.,Cange Abby L.,Sabatine Marc S.,O’Donoghue Michelle L.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-020-02221-5.pdf

Reference18 articles.

1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on Epidemiology, Prevention Statistics Committee, Stroke Statistics Subcommittee (2019) Heart disease and stroke statistics—2019 update: a Report from the American Heart Association. Circulation 139(10):e56–e528. https://doi.org/10.1161/CIR.0000000000000659

2. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, AATF Members (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130(25):e344–e426. https://doi.org/10.1161/CIR.0000000000000134

3. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O’Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2016) 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 133(11):1135–1147. https://doi.org/10.1161/CIR.0000000000000336

4. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM, DS Investigators (2014) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371(23):2155–2166. https://doi.org/10.1056/NEJMoa1409312

5. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L, DS Investigators (2016) Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 315(16):1735–1749. https://doi.org/10.1001/jama.2016.3775

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice;Molecular Biotechnology;2024-01-06

2. Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression;Journal of Clinical Medicine;2023-10-10

3. Ventricular function and biomarkers in relation to repair and pulmonary valve replacement for tetralogy of Fallot;Open Heart;2023-04

4. Mechanism Research of Platelet Core Marker Prediction and Molecular Recognition in Cardiovascular Events;Combinatorial Chemistry & High Throughput Screening;2023-01

5. Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention;Coronary Artery Disease;2022-11-22